Vittorio Pengo

27.8k total citations · 6 hit papers
367 papers, 16.3k citations indexed

About

Vittorio Pengo is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Hematology. According to data from OpenAlex, Vittorio Pengo has authored 367 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Cardiology and Cardiovascular Medicine, 139 papers in Rheumatology and 125 papers in Hematology. Recurrent topics in Vittorio Pengo's work include Systemic Lupus Erythematosus Research (139 papers), Atrial Fibrillation Management and Outcomes (130 papers) and Venous Thromboembolism Diagnosis and Management (97 papers). Vittorio Pengo is often cited by papers focused on Systemic Lupus Erythematosus Research (139 papers), Atrial Fibrillation Management and Outcomes (130 papers) and Venous Thromboembolism Diagnosis and Management (97 papers). Vittorio Pengo collaborates with scholars based in Italy, United States and United Kingdom. Vittorio Pengo's co-authors include Amelia Ruffatti, Gualtiero Palareti, Sabino Iliceto, Armando Tripodi, Alessandra Biasiolo, Gentian Denas, Sophie Testa, Cristina Legnani, Elisa Bison and Angelo Ghirarduzzi and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Vittorio Pengo

349 papers receiving 15.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism

2004 1.2k citations Vittorio Pengo, Sabino Iliceto et al. profile →
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

1996 1.0k citations Gualtiero Palareti, Cesare Manotti et al. profile →
Update of the guidelines for lupus anticoagulant detection

2009 855 citations Vittorio Pengo, Armando Tripodi et al. Journal of Thrombosis and Haemostasis profile →
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients

2007 550 citations Vittorio Pengo et al. profile →
Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

2009 435 citations Vittorio Pengo, Amelia Ruffatti et al. Journal of Thrombosis and Haemostasis profile →
Chronic Thromboembolic Pulmonary Hypertension

2013 355 citations Vittorio Pengo et al. profile →

Peers

Countries citing papers authored by Vittorio Pengo

Since Specialization

Citations

This map shows the geographic impact of Vittorio Pengo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittorio Pengo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittorio Pengo more than expected).

Fields of papers citing papers by Vittorio Pengo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vittorio Pengo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittorio Pengo. The network helps show where Vittorio Pengo may publish in the future.

Co-authorship network of co-authors of Vittorio Pengo

This figure shows the co-authorship network connecting the top 25 collaborators of Vittorio Pengo. A scholar is included among the top collaborators of Vittorio Pengo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittorio Pengo. Vittorio Pengo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Domain and residue mapping of autoantibodies to β2GPI reveals differences among antiphospholipid syndrome phenotypes 2025 ·Blood ·Suresh Kumar, (unknown), Paola Adele Lonati, (unknown), Marta Tonello, Pier Luigi Meroni, Vittorio Pengo, Nicola Pozzi	0
2	Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 2024 ·International Journal of Laboratory Hematology ·(unknown), (unknown), Gilda Sandri, Daniela Poli, Piera Sivera, (unknown), Domenico Prisco, (unknown), (unknown), Emilia Antonucci, Gualtiero Palareti, Vittorio Pengo, (unknown)	2
3	Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody 2024 ·Blood ·Suresh Kumar, (unknown), Katherine Basore, Vittorio Pengo, Robert Flaumenhaft, Nicola Pozzi	2
4	Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging 2024 ·European Heart Journal ·Raffaele De Caterina, Hugo Ten Cate, Vittorio Pengo	3
5	Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension 2023 ·European Journal of Internal Medicine ·Rui Zhu, (unknown), Gentian Denas, Vittorio Pengo	4
6	Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody–positive subjects 2023 ·Journal of Thrombosis and Haemostasis ·Elena Pontara, Elisa Bison, Maria Grazia Cattini, Marta Tonello, Gentian Denas, Vittorio Pengo	4
7	Fluctuation of Anti–Domain 1 and Anti–β₂‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies 2023 ·Arthritis & Rheumatology ·Cecilia Beatrice Chighizola, Francesca Pregnolato, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza, H. Michael Belmont, Maria Gerosa, Paul R. Fortin, D. Ware Branch, Laura Andréoli, Michelle Petri, Ricard Cervera, Jason S. Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, María Laura Bertolaccini	12
8	Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis 2020 ·Journal of Thrombosis and Haemostasis ·Katrien Devreese, Philip G. de Groot, Bas de Laat, Doruk Erkan, Emmanuel J. Favaloro, Ian Mackie, Marta Martinuzzo, Thomas L. Ortel, Vittorio Pengo, Jacob H. Rand, Armando Tripodi, Denis Wahl, Hannah Cohen	245
9	Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register 2020 ·BMJ Open ·Gualtiero Palareti, Emilia Antonucci, Cristina Legnani, Daniela Mastroiacovo, Daniela Poli, Paolo Prandoni, Alberto Tosetto, Vittorio Pengo, Sophie Testa, Walter Ageno	9
10	Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry 2019 ·Angiology ·Plinio Cirillo, Luigi Di Serafino, (unknown), Paolo Calabrò, Emilia Antonucci, Paolo Gresele, Gualtiero Palareti, Giuseppe Patti, Vittorio Pengo, Pasquale Pignatelli, Rossella Marcucci	2
11	Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry 2018 ·Angiology ·Paolo Calabrò, Felice Gragnano, Marco Di Maio, Giuseppe Patti, Emilia Antonucci, Plinio Cirillo, Paolo Gresele, Gualtiero Palareti, Vittorio Pengo, Pasquale Pignatelli, Mauro Pennacchi, Antonino Granatelli, Stefano De Servi, Leonardo De Luca, Rossella Marcucci, (unknown)	28
12	Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study 2018 ·International Journal of Cardiology ·Daniela Poli, Emilia Antonucci, Vittorio Pengo, Ludovica Migliaccio, Sophie Testa, Corrado Lodigiani, (unknown), (unknown), (unknown), Pietro Falco, (unknown), (unknown), L. Ruocco, Raffaele De Caterina, Gualtiero Palareti	31
13	Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 2018 ·Angiology ·Plinio Cirillo, Luigi Di Serafino, Giuseppe Patti, Emilia Antonucci, Paolo Calabrò, Paolo Gresele, Gualtiero Palareti, Vittorio Pengo, Pasquale Pignatelli, Rossella Marcucci	18
14	Indagine Censis sulla conoscenza in Italia della fibrillazione atriale a livello dei cittadini, dei medici di medicina generale e dei pazienti 2014 ·Giornale italiano di cardiologia ·Gian Franco Gensini, Giuseppe Di Pasquale, Concetta M. Vaccaro, Letizia Riva, Ido Iori, Carlo Nozzoli, Vittorio Pengo, Stefano Ricci, Massimo Santini, Danilo Toni	5
15	Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results 2012 ·Journal of Thrombosis and Haemostasis ·Vittorio Pengo, L. Crippa, Anna Falanga, Guido Finazzi, Francesco Marongiu, Marco Moia, Gualtiero Palareti, Daniela Poli, Sophie Testa, Eros Tiraferri, Alberto Tosetto, Armando Tripodi, S. Siragusa, Cesare Manotti	24
16	Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies 2011 ·Lupus ·Guillermo Ruiz‐Irastorza, (unknown), Ioana Ruiz‐Arruza, Robin L. Brey, Mark Crowther, (unknown), Doruk Erkan, Steven A. Krilis, Sam Machin, Vittorio Pengo, Silvia S. Pierangeli, Maria G. Tektonidou, Munther A. Khamashta	323
17	Critical Update of the Antiphospholipid Syndrome Criteria 2010 ·Vittorio Pengo, Amelia Ruffatti	1
18	Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery 2009 ·Circulation ·Vittorio Pengo, Umberto Cucchini, Gentian Denas, Nicoletta Erba, Giuliana Guazzaloca, L. La Rosa, Valeria Micheli, Sophie Testa, (unknown), Domenico Prisco, Giovanni Nante, Sabino Iliceto	97
19	VENOUS THROMBOEMBOLISM RECURRENCE AFTER A FIRST EPISODE OF PROVOKED VENOUS THROMBOSIS DUE TO A TRANSIENT RISK FACTOR. A SYSTEMATIC REVIEW OF THE LITERATURE 2008 ·Esmeralda Filippucci, Clive Kearon, Maura Marcucci, Vittorio Pengo, S. Siragusa, Gualtiero Palareti, Alfonso Iorio	4
20	Descriptive Analysis of the Process and Quality of Oral Anticoagulation Management in Real-Life Practice in Patients with Chronic Non-valvular Atrial Fibrillation 2007 ·UCL Discovery (University College London) ·Jack Ansell, Jennifer Hollowell, Vittorio Pengo, (unknown), J. Jaime, Ludovic Drouet	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact